Essex Woodlands Health Ventures

Latest statistics and disclosures from Essex Woodlands Health Ventures's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are ABMD, Revance Therapeutics, Axogen, Corium Intl, Entellus Medical Cm, and represent 96.51% of Essex Woodlands Health Ventures's stock portfolio.
  • Reduced shares in these 1 stocks: .
  • Sold out of its positions in Ligand Pharmaceuticals In.
  • Essex Woodlands Health Ventures was a net seller of stock by $3.28M.
  • Essex Woodlands Health Ventures has $553.05M in assets under management (AUM), growing by 26.19%.

Companies in the Essex Woodlands Health Ventures portfolio as of June 2017 quarter

Company (Ticker) Portfolio Weight Share Count Change in Shares Price
ABIOMED (ABMD) 37.57 1.45M 143.30
Revance Therapeutics 21.92 4.59M 26.40
Axogen 14.72 4.86M 16.75
Corium Intl 12.62 9.35M 7.46
Entellus Medical Cm 9.68 3.23M 16.56
Endologix (ELGX) 2.11 1.26M 9.30
MediciNova (MNOV) 1.11 1.17M 5.26
Acura Pharmaceuticals 0.20 1.96M 0.56
Catalyst Biosciences 0.07 78622 4.73

Past 13F-HR SEC Filings by Essex Woodlands Health Ventures

View All Filings